Österreich - Deutsch - AGES (Agentur für Gesundheit und Ernährungssicherheit)

orifarm gmbh - natrium mycophenolat -

Österreich - Deutsch - AGES (Agentur für Gesundheit und Ernährungssicherheit)

orifarm gmbh - natrium mycophenolat -

Österreich - Deutsch - AGES (Agentur für Gesundheit und Ernährungssicherheit)

haemato pharm gmbh - natrium mycophenolat -

Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

stadapharm gmbh (3364435) - magensaftresistente tablette - 360 mg mycophenolsäure

Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

stadapharm gmbh (3364435) - magensaftresistente tablette - 180 mg mycophenolsäure

Europäische Union - Deutsch - EMA (European Medicines Agency)

janssen-cilag international nv - ibrutinib - lymphoma, mantle-cell; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, protein kinase inhibitors - imbruvica as a single agent is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl). imbruvica as a single agent or in combination with rituximab or obinutuzumab or venetoclax is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. imbruvica as a single agent or in combination with bendamustine and rituximab (br) is indicated for the treatment of adult patients with cll who have received at least one prior therapy. imbruvica as a single agent is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo immunotherapy. imbruvica in combination with rituximab is indicated for the treatment of adult patients with wm.

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - mofetili mycophenolas - kapseln - mofetili mycophenolas 250 mg, carmellosum natricum nur zusammen gehalten, color.: e 132, excipiens pro kapsel. - immunsuppressivum - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - mofetili mycophenolas - filmtabletten - mofetili mycophenolas 500 mg, carmellosum natricum nur zusammen gehalten, color.: e 132, excipiens pro compresso dunst. - immunsuppressivum - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - mofetili mycophenolas - pulver zur herstellung einer suspension zum einnehmen - mofetili mycophenolas 200 mg, lecithinum ex soja, arom.: vanillinum et alia, aspartamum, sorbitolum, conserv.: e 218, excipiens ad pulverem corresp. suspensio reconstituta 1 ml. - immunsuppressivum - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - mofetili mycophenolas - kapseln - mofetili mycophenolas 250 mg, color.: e 132, excipiens pro kapsel. - immunsuppressivum - synthetika